Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current trends in drug-induced autoimmunity

J P Uetrecht1

  • 1Faculty of Pharmacy, University of Toronto, Sunnybrook Health Science Centre, Ontario, Canada.

Toxicology
|April 11, 1997
PubMed
Summary

Drug-induced autoimmunity, like drug-induced lupus, likely involves immune responses to drug metabolites. These reactive metabolites may bind to structures, triggering immune reactions or autoantibodies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A fresh look at the mechanism of isoniazid-induced hepatotoxicity.

Clinical pharmacology and therapeutics·2011
Same author

Nevirapine hypersensitivity.

Handbook of experimental pharmacology·2009
Same author

Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis.

Chemico-biological interactions·2002
Same author

Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system.

Current drug metabolism·2002
Same author

Factors that modify penicillamine-induced autoimmunity in Brown Norway rats: failure of the Th1/Th2 paradigm.

Toxicology·2001
Same author

Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions?

Current drug metabolism·2001

Area of Science:

  • Immunology
  • Pharmacology
  • Toxicology

Background:

  • Idiosyncratic adverse drug reactions often suggest immune system involvement.
  • Drug-induced lupus is an autoimmune syndrome that is immune-mediated.
  • Reactive drug metabolites are hypothesized to be key in initiating drug-induced autoimmunity.

Purpose of the Study:

  • To explore the mechanisms of drug-induced autoimmunity.
  • To investigate the role of reactive metabolites in immune-mediated drug reactions.
  • To understand the complex pathways leading to autoantibody production.

Main Methods:

  • Review of existing hypotheses on drug metabolism and immune responses.
  • Analysis of the role of NADPH oxidase/myeloperoxidase system in reactive metabolite formation.
  • Consideration of molecular mimicry and altered antigen presentation in autoimmunity.

Main Results:

  • Reactive metabolites may irreversibly bind to cellular structures, initiating immune responses.
  • The liver is a primary site for drug metabolism and a common target for idiosyncratic reactions.
  • Immune reactions involving leukocytes may stem from reactive metabolites formed by the NADPH oxidase/myeloperoxidase system.
  • Autoantibodies can be produced, sometimes independently of the drug, suggesting complex mechanisms like molecular mimicry or altered antigen presentation.

Conclusions:

  • Reactive drug metabolites are strongly implicated in the initiation of drug-induced autoimmunity.
  • The immune response can involve antibodies or T-cells against altered structures, or more complex mechanisms.
  • Further research is needed to fully elucidate the pathways leading to drug-induced autoimmune syndromes.

Related Experiment Videos